Madison Lyn Carey, PA-C

Madison Carey practices at Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania.

Madison Carey's NPI, 1194207928, was assigned on August 29, 2018. Madison Carey holds Pennsylvania license MA060791.

Madison Carey's primary practice is Penn Medicine Lancaster General Health Physicians Hematology &Oncology, at 2102 Harrisburg Pike, Lancaster, PA 17601 in Lancaster County. The practice phone is (717) 544-9400.

Madison Carey's primary practice is Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania. Madison Carey is also affiliated with Lancaster General Hospital. The medical group on file is Penn Medicine Lancaster General Health Physicians, Behavioral Health. Dmand AI also links Madison Carey to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Madison Carey practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Madison Carey's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Madison Carey's licenses on file in 2 states: Pennsylvania and Delaware.

CMS counts 286 Medicare patients who saw Madison Carey in 2024. The largest group is 65 to 74, with 144 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Madison Carey's median patient age at 71, with 56% women.

In 2024, Madison Carey wrote 1,114 Medicare Part D claims for 353 patients. 72% of them were for generic drugs.

Madison Carey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Madison Carey from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $125.